These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Possibilities and limits of non-hormonal therapy of the menopausal syndrome]. Piccione E; Sesti F; Manna C Clin Ter; 1984 Nov; 111(4):359-65. PubMed ID: 6396027 [No Abstract] [Full Text] [Related]
4. [Our experience in using bromocriptine-Richter in gynecology (a preliminary report)]. Marinov B; Tsankova M; Kolarov G Akush Ginekol (Sofiia); 2000; 39 Suppl 1():20-1. PubMed ID: 10948639 [No Abstract] [Full Text] [Related]
5. [The treatment of the climacteric syndrome in women suffering from Itsenko-Cushing disease and primary obesity]. Manusharova RA Lik Sprava; 1992 Jan; (1):94-6. PubMed ID: 1364624 [TBL] [Abstract][Full Text] [Related]
6. [Use of 6-(10-dihydroxyundecyl)-beta-resorcylic acid mu-lactone in the therapy of the climacteric syndrome and menopause]. Locardi G; Guglielmetti D Minerva Ginecol; 1975 Sep; 27(9):754-72. PubMed ID: 1207967 [No Abstract] [Full Text] [Related]
8. [Modern drug treatment of hyperprolactinemia]. Rachev E; Spasov S Akush Ginekol (Sofiia); 1985; 24(6):81-4. PubMed ID: 3911788 [No Abstract] [Full Text] [Related]
9. [Follow-up of the effect of prolactin-lowering substances]. Gazárek F; Talas M; Stehlíková J; Zenísek L; Fingerová H Acta Univ Palacki Olomuc Fac Med; 1981; 101():102-9. PubMed ID: 6242680 [No Abstract] [Full Text] [Related]
10. [Treatment of climacteric symptoms after artificial menopause]. Radocha K; Dokládalová D; Vácha K Cas Lek Cesk; 1972 Feb; 111(7):158-60. PubMed ID: 5010322 [No Abstract] [Full Text] [Related]
11. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine? Smith S J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of the climacteric syndrome]. Moraweck W Dtsch Med J; 1969 Apr; 20(8):273-5. PubMed ID: 4394461 [No Abstract] [Full Text] [Related]
13. [The current principles of the hormonal therapy of patients with the climacteric syndrome]. Gudkova MA Akush Ginekol (Mosk); 1994; (2):7-11. PubMed ID: 8017586 [No Abstract] [Full Text] [Related]
14. [The modification of thyroid dysfunction by hormone substitution in the climacteric]. Kurz H; Metka M; Enzelsberger H; Heytmanek G; Schurz B; Huber J; Spona J Gynakol Rundsch; 1989; 29(4):243-5. PubMed ID: 2560762 [No Abstract] [Full Text] [Related]
15. [Hormone substitution in climacteric and postmenopause. Consensus report of the Austrian Menopause Society]. Metka M; Heytmanek G; Enzelsberger H; Kurz C; Huber J; Brandstätter N; Tscherne G; Tabarelli M; Holzer G Wien Med Wochenschr; 1992; 142(5-6):94-5. PubMed ID: 1615684 [No Abstract] [Full Text] [Related]
16. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report. Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977 [No Abstract] [Full Text] [Related]